Treatment and prognosis of recurrent uterine leiomyosarcomas in last 5 years

被引：0
|
作者：
Saito, Tsuyoshi [1 ]
Tanaka, Rhoichi [2 ]
Satohisa, Seiro [1 ]
Abe, Shuetsu [1 ]
Iwasaki, Masahiro [1 ]
Teramoto, Mizue [1 ]
Matsuura, Motoki [1 ]
Tamate, Masato [1 ]
机构：
[1] Sapporo Med Univ, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan
[2] Tonan Hosp, Gynecol, Saporo, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2018年 / 28卷
关键词：
leiomyosarcoma; surgery; chemotherapy; reccurence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3714
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] PROGNOSIS OF UTERINE LEIOMYOSARCOMAS BASED ON HISTOPATHOLOGIC CRITERIA
    LABERGE, JL
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1962, 84 (12) : 1833 - &
  • [2] A Review of Treatment of Uterine Leiomyosarcomas
    Reed, Nicholas
    CURRENT ONCOLOGY REPORTS, 2013, 15 (06) : 581 - 587
  • [3] Pharmacological treatment for uterine leiomyosarcomas
    Gadducci, Angiolo
    Guerrieri, Maria Elena
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (03) : 335 - 346
  • [4] A Review of Treatment of Uterine Leiomyosarcomas
    Nicholas Reed
    Current Oncology Reports, 2013, 15 : 581 - 587
  • [5] Genomic alterations in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis
    Hu, J
    Khanna, V
    Jones, M
    Surti, U
    GENES CHROMOSOMES & CANCER, 2001, 31 (02): : 117 - 124
  • [6] Cyclooxygenase-2 Is an Independent Predictor of Poor Prognosis in Uterine Leiomyosarcomas
    Lee, Chae Hyeong
    Roh, Ju-Won
    Choi, Jong-Sun
    Kang, Sokbom
    Park, In-Ae
    Chung, Hyun Hoon
    Jeon, Yong-Tark
    Kim, Jae Weon
    Park, Noh-Hyun
    Kang, Soon-Beom
    Song, Yong-Sang
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 668 - 672
  • [7] Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas
    Ferrero, Simone
    Maggiore, Umberto Leone Roberti
    Aiello, Nicoletta
    Barra, Fabio
    Ditto, Antonino
    Bogani, Giorgio
    Raspagliesi, Francesco
    Lorusso, Domenica
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (08) : 881 - 889
  • [8] Genomic alterations in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis.
    Hu, J
    Khanna, V
    Jones, M
    Surti, U
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 70 - 70
  • [9] FOLLOW UP IN PATIENTS WITH UTERINE LEIOMYOSARCOMAS: OUR 20 YEARS EXPERIENCE
    Vaidakis, D.
    Goudeli, C.
    Pilatec, L.
    Danilatos, G.
    Papapanagiotou, J.
    Terzakis, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 61 - 61
  • [10] DETERIORATION OF INHERENT TREATMENT PROGNOSIS OF INFERTILITY PATIENTS OVER THE LAST 5 YEARS (2012-2016).
    Gleicher, N.
    Barad, D. H.
    Darmon, S.
    Kushnir, V. A.
    FERTILITY AND STERILITY, 2017, 108 (03) : E344 - E345
12345